Highlights and Quick Summary
- Shareholders Equity (Tangible) for the quarter ending September 30, 2023 was $147 Million (a -10.96% decrease compared to previous quarter)
- Year-over-year quarterly Shareholders Equity (Tangible) decreased by -26.87%
- Annual Shareholders Equity (Tangible) for 2022 was $201 Million (a -30.48% decrease from previous year)
- Annual Shareholders Equity (Tangible) for 2021 was $290 Million (a 332.48% increase from previous year)
- Annual Shareholders Equity (Tangible) for 2020 was $67 Million (a 477.43% increase from previous year)
Visit stockrow.com/ABSI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Shareholders Equity (Tangible) of Absci Corporation
Most recent Shareholders Equity (Tangible)of ABSI including historical data for past 10 years.Interactive Chart of Shareholders Equity (Tangible) of Absci Corporation
Absci Corporation Shareholders Equity (Tangible) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $147.32 | $165.46 | $181.85 | – | – |
| 2022 | $201.46 | $219.14 | $241.55 | $265.01 | $201.46 |
| 2021 | $289.78 | $309.17 | $-42.46 | $59.41 | $289.78 |
| 2020 | – | – | – | $67.01 | $67.01 |
| 2019 | $11.6 | – | – | – | $11.6 |
Business Profile of Absci Corporation
Sector: Healthcare
Industry: Biotechnology